Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
ConditionPancreas Cyst
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-120
SponsorMayo Clinic
About this trial
Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Eligibility criteria
Qualifiers
Patients with pancreatic cystic lesions meeting Fukuoka worrisome or Fukuoka high-risk criteris
Patients with suspected cystic neoplasm of the pancreas
Able to provide written informed consent
Disqualifiers
Pregnant and/or nursing
Incarceration
Imaging showing possible pancreatic cancer
Prior history of pancreatic cancer or pancreatic surgery
Trial design
Treatments tested in this trial
- Blood, stool, pancreatic juice and cyst fluid collection
- Pancreatic Surgery
- Endoscopy Exam
Treatment groups
800 Participants
are divided into 2 treatment groupsSponsors and collaborators
Mayo Clinic
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov